Clinical Trials in Ottawa, United States
Locations / Ottawa, United States
Delta Trials hosts 91 clinical trials conducted in Ottawa, United States, making it a notable site of clinical research activity. These trials covering 633 medical conditions and multiple therapeutic areas, reflecting the scope and diversity of clinical research in this location. The trial counts on this page reflect the most recent data ingested from ClinicalTrials.gov, tracking research history across multiple versions for Ottawa.
91
Total Trials
633
Conditions
0
Terminated since 2020
Browse by condition (633 total)
- Stage iiib lung cancer ajcc v8 5 trialsAll Stage iiib lung cancer ajcc v8 trials
- Stage ii lung cancer ajcc v8 5 trialsAll Stage ii lung cancer ajcc v8 trials
- Recurrent ovarian carcinoma 5 trialsAll Recurrent ovarian carcinoma trials
- All Stage iiia lung non-small cell cancer ajcc v7 trials
- All Clinical stage iii cutaneous melanoma ajcc v8 trials
- Lung non-small cell carcinoma 4 trialsAll Lung non-small cell carcinoma trials
- Stage iiia lung cancer ajcc v8 4 trialsAll Stage iiia lung cancer ajcc v8 trials
- Sarcomatoid renal cell carcinoma 3 trialsAll Sarcomatoid renal cell carcinoma trials
- Malignant solid neoplasm 3 trialsAll Malignant solid neoplasm trials
- Recurrent fallopian tube carcinoma 3 trialsAll Recurrent fallopian tube carcinoma trials
- All Stage ib lung non-small cell carcinoma ajcc v7 trials
- All Recurrent ovarian endometrioid adenocarcinoma trials
- All Recurrent ovarian clear cell adenocarcinoma trials
- Metastatic malignant solid neoplasm 3 trialsAll Metastatic malignant solid neoplasm trials
- Stage iii lung cancer ajcc v8 3 trialsAll Stage iii lung cancer ajcc v8 trials
- All Stage ii lung non-small cell cancer ajcc v7 trials
- Advanced malignant solid neoplasm 3 trialsAll Advanced malignant solid neoplasm trials
- All Recurrent primary peritoneal carcinoma trials
- Neuroendocrine tumor g2 3 trialsAll Neuroendocrine tumor g2 trials
- Ovarian seromucinous carcinoma 3 trialsAll Ovarian seromucinous carcinoma trials